Zhouying Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhouying Li has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Hua Shi
School of Opto-electronic and Communication Engineering, Xiamen University of Technology , Ligong Road, Jimei District, Xiamen, Fujian 361024
1 shared publication- Hui Yang
Yangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, Zhejiang, China
1 shared publication - Quan Zou
Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, China
1 shared publication
Latest Publications
- Open Access
- 2 July 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (4)
Research on RNA modification in disease diagnosis and prognostic biomarkers: current status and challenges
RNA modification, as a crucial post-transcriptional regulatory mechanism, plays a pivotal role in normal physiological processes and is closely associated with the onset and progression of various human diseases. Recent studies have highlighted significant alterations in the level of RNA modifications, including m6A, m6Am, m1A, m5C, m7G, ac4C, Ψ, and A-to-I editing, across multiple diseases. These findings suggest the potential of RNA modifications and their regulatory factors as biomarkers for early disease diagnosis and prognosis. This review provides an overview of statistical methods, machine learning techniques employed in identifying disease diagnostic and prognostic biomarkers, along with relevant evaluation metrics and bioinformatics tools. We further explore the types of common RNA modifications, the modifying proteins involved, and the underlying mechanisms of modification. The focus of this paper is on the application of machine learning algorithms in discovering RNA modification-related biomarkers, particularly for disease diagnosis and prognosis. By reviewing recent advancements in the identification of disease biomarkers, and analyzing the prospects and challenges of their clinical application, we aim to offer insights into the mining methods of RNA modifications and their associated factors as disease diagnostic or prognostic biomarkers, providing a valuable reference for future research and clinical practice.
- 2 July 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (4)
Open AccessResearch on RNA modification in disease diagnosis and prognostic biomarkers: current status and challenges
RNA modification, as a crucial post-transcriptional regulatory mechanism, plays a pivotal role in normal physiological processes and is closely associated with the onset and progression of various human diseases. Recent studies have highlighted significant alterations in the level of RNA modifications, including m6A, m6Am, m1A, m5C, m7G, ac4C, Ψ, and A-to-I editing, across multiple diseases. These findings suggest the potential of RNA modifications and their regulatory factors as biomarkers for early disease diagnosis and prognosis. This review provides an overview of statistical methods, machine learning techniques employed in identifying disease diagnostic and prognostic biomarkers, along with relevant evaluation metrics and bioinformatics tools. We further explore the types of common RNA modifications, the modifying proteins involved, and the underlying mechanisms of modification. The focus of this paper is on the application of machine learning algorithms in discovering RNA modification-related biomarkers, particularly for disease diagnosis and prognosis. By reviewing recent advancements in the identification of disease biomarkers, and analyzing the prospects and challenges of their clinical application, we aim to offer insights into the mining methods of RNA modifications and their associated factors as disease diagnostic or prognostic biomarkers, providing a valuable reference for future research and clinical practice.